In this blog, well break down the benefits of each to help you make an informed decision
10.3945/ajcn.110.009340 117 ZhangZ.AtwellL
Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, Marsolais C, Turner R, Grinspoon S
Similar to nonsilent immune forms of regulated necrosis, ferroptotic cell death can release damage-associated molecular patterns (DAMPs) that promote the development of multiple inflammatory diseases and trigger the innate immune system
Dose-Dependent Adverse Event Patterns One of the clearest findings from published retatrutide data is the dose-dependent relationship with adverse events: Lower doses (1 mg): GI event rates only modestly above placebo Mid-range doses (4-8 mg): GI event rates of 57-64%, with dose escalation reducing peak incidence Highest dose (12 mg): GI event rates of ~67%, though most events were mild-to-moderate and transient The Phase 2 trial included both "single-dose" and "escalated-dose" cohorts for the 4 mg and 8 mg groups
Ipamorelin isnt typically considered a liver-support peptide